Insilico Medicine (“Insilico”, 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence ...
GSK’s own proprietary platform is called Cogito Forge. It is not a standard AI search model, but one that uses ‘agents’ that ...
A reversal of cuts to the National Institutes of Health budget has life sciences operators breathing a sigh of relief.
HCW Biologics receiving cash fee and co-founder shares in Trimmunevalued at $7.0 million Trimmune will hold exclusive worldwide license for rights to high potential preclinical molecule created with ...
October, the company announced that it is withdrawing the financial targets communicated on 1 June 2022. The targets are currently under revision ...
From camera-ready escarpments on the Blantyre-Chikwawa Road, PressCane Limited’s ethanol distillery in the Shire Valley pops into view like a smoke-free miniature placed on the west bank of Malawi’s ...
Chinese pharmaceutical companies that as a group chalked up record outbound licensing agreements with international industry ...
Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left ...
A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...
SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to major medical advances -- but it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results